SCYNEXIS Inc (NASDAQ:SCYX)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - SCYX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - SCYX
- Market Cap$156.360m
- SymbolNASDAQ:SCYX
- IndustryHealthcare
- SectorDrug Manufacturers - Specialty & Generic
- Currency
- ISINUS8112922005
Company Profile
SCYNEXIS Inc is drug development company which focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing lead product candidate, SCY-078 which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The SCY-078 is a novel and structurally distinct triterpenoid glucan synthase inhibitor which is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains.SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.
Latest SCYX news
Currently there for this company. Visit our news hub for other news .